Vidya Nadar

What is this session?

• With a high concentration of relevant companies in one place, the pharma icebreaker tables offer a guaranteed opportunity for face-to-face interactions. Whether you’re connected on the One-on-One Partnering™ portal or not, this is a protected opportunity to introduce yourself and your organization

How is this organized?

• Two weeks out from the conference, pharma will review attending biotech and biotech will review attending pharma, with both making selections to meet with companies they haven’t scheduled meetings with yet and are working in areas of strategic interest
• With these selections, we will build a schedule of company rotations through each pharma’s table, across 90 minutes

• Comparing sentiment towards neuroscience deal-making, including: which stage of development is most appealing, which modalities are of interest, and what are the key elements of differentiation?
• Discussing data expectations to open a discussion. Guidance on data package and biomarker preferences seen as most credible or promising to generate interest for a deal decision
• Providing the best advice on what is expected when approaching any partner, understanding how to differentiate decks in crowded and sharing insights into types of interactions around early-stage and pre-IND